TScan Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress November 11, 2021
Renovia receives Breakthrough Device Designation for leva® Digital Therapeutic as First-Line Treatment for Chronic Fecal Incontinence November 1, 2021
Rectify Pharmaceuticals Launches with $100 Million Series A Financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund October 14, 2021
Axial Therapeutics Raises $37.25 Million in Series C Financing to Advance its Pipeline of Gut-Targeted Small Molecule Drugs for Neurological Diseases and Disorders October 13, 2021
